These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 15198361

  • 1. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC, Chen PC, Chiang H.
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [Abstract] [Full Text] [Related]

  • 2. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [Abstract] [Full Text] [Related]

  • 3. Expression of vitamin D3 receptor in kidney tumors.
    Liu W, Tretiakova M, Kong J, Turkyilmaz M, Li YC, Krausz T.
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [Abstract] [Full Text] [Related]

  • 4. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
    Kuroda N, Inoue K, Guo L, Miyazaki E, Hayashi Y, Naruse K, Toi M, Hiroi M, Shuin T, Enzan H.
    Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
    [Abstract] [Full Text] [Related]

  • 5. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP, Gupta A, Lin F, Luan C, Teh BT, Yang XJ.
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [Abstract] [Full Text] [Related]

  • 6. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma.
    Krüger S, Sotlar K, Kausch I, Horny HP.
    Oncology; 2005 Jul; 68(2-3):269-75. PubMed ID: 16015044
    [Abstract] [Full Text] [Related]

  • 7. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [Abstract] [Full Text] [Related]

  • 8. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
    Taki A, Nakatani Y, Misugi K, Yao M, Nagashima Y.
    Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
    [Abstract] [Full Text] [Related]

  • 9. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
    Tickoo SK, Amin MB, Linden MD, Zarbo RJ.
    Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
    [Abstract] [Full Text] [Related]

  • 10. C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma.
    Zimpfer A, Janke S, Hühns M, Schneider B, Kundt G, Zettl H, Kilic E, Maruschke M, Hakenberg OW, Erbersdobler A.
    Pathol Res Pract; 2014 Aug; 210(8):521-5. PubMed ID: 24875296
    [Abstract] [Full Text] [Related]

  • 11. S100A1 and KIT gene expressions in common subtypes of renal tumours.
    Li G, Gentil-Perret A, Lambert C, Genin C, Tostain J.
    Eur J Surg Oncol; 2005 Apr; 31(3):299-303. PubMed ID: 15780567
    [Abstract] [Full Text] [Related]

  • 12. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Li G, Barthelemy A, Feng G, Gentil-Perret A, Peoc'h M, Genin C, Tostain J.
    Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
    [Abstract] [Full Text] [Related]

  • 13. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC, Chen PC, Ho DM.
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [Abstract] [Full Text] [Related]

  • 14. KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis.
    Kato N, Honma K, Hojo H, Sasou S, Matsuzaki O, Motoyama T.
    Pathol Int; 2005 Aug; 55(8):479-83. PubMed ID: 15998375
    [Abstract] [Full Text] [Related]

  • 15. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
    Yakirevich E, Matoso A, Sabo E, Wang LJ, Tavares R, Meitner P, Morris DJ, Pareek G, Delellis RA, Resnick MB.
    Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC, Barocas DA, Chen YT, Yang XJ, Scherr DS, Tu JJ.
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of BHD in sporadic renal tumors.
    Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K, Ludlow J, Knapp R, Giraud S, Richard S, Nordenskjöld M, Teh BT.
    Cancer Res; 2003 Aug 01; 63(15):4583-7. PubMed ID: 12907635
    [Abstract] [Full Text] [Related]

  • 18. Alpha-methyl CoA racemase expression in renal cell carcinomas.
    Molinié V, Balaton A, Rotman S, Mansouri D, De Pinieux I, Homsi T, Guillou L.
    Hum Pathol; 2006 Jun 01; 37(6):698-703. PubMed ID: 16733210
    [Abstract] [Full Text] [Related]

  • 19. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
    Nagy A, Buzogany I, Kovacs G.
    Histopathology; 2004 Jun 01; 44(6):542-6. PubMed ID: 15186268
    [Abstract] [Full Text] [Related]

  • 20. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
    Zigeuner R, Ratschek M, Langner C.
    BJU Int; 2005 Feb 01; 95(3):315-8. PubMed ID: 15679785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.